Buccal delivery offers a promising alternative to oral drug administration by enabling direct systemic absorption and avoiding first-pass metabolism. Multilayer polymeric films represent a promising

Health Canada is warning Canadians of the dangers of buying “fake or unauthorized products” meant to replicate popular GLP-1 drugs such as Ozempic, Rybelsus and

The funding will support a GLP-1 pill Corxel licensed from China-based Vincentage in 2024 and that the company believes to be as effective in spurring

This story discusses suicide. If you or someone you know is having thoughts of suicide, please contact the Suicide & Crisis Lifeline at 988 or

Quick Read Magnificent Seven stocks are in the red for 2026 as collective momentum has stalled. Eli Lilly partnered with Nvidia on drug discovery as

Medifast, Inc.’s MED guidance for the fourth quarter of 2025 remains weak, with revenue projected to be between $65 million and $80 million and a

Image source: The Motley Fool. Date Thursday, Feb. 6, 2025 at 10 a.m. ET Call participants Chair and Chief Executive Officer — David A. Ricks

Image source: The Motley Fool. Date Wednesday, Oct. 30, 2024 at 10:00 a.m. ET Call participants Chairman and Chief Executive Officer — David A. Ricks

Image source: The Motley Fool. Date Aug. 7, 2025 at 8:30 a.m. ET Call participants Chairman and Chief Executive Officer — David A. Ricks Chief

Who would have ever thought that a weight loss injectable would become a household name and pop culture-adjacent phenomenon? Ozempic has become synonymous with modern

Richard M Lee/Shutterstock Consumers are surrounded by food that is highly conducive to weight gain. No one likes dieting and very few have lasting success.

Many patients may keep off lost pounds after stopping a GLP-1, US data suggests  Reuters

GLP-1 medications can create opportunity for change—but environment determines what lasts. Discover how context shapes habits more than motivation alone.

In a reminder of the money still available for enticing obesity assets, Corxel Pharmaceuticals has raised $287 million in series D funds to bankroll phase

A University of Oxford study published in The BMJ finds users of GLP-1 drugs like Ozempic regain weight and reverse heart health improvements within two

Since its 2019 founding, Corxel Pharmaceuticals has evolved from focusing on the China market to eyeing the world. The biopharma, founded in Shanghai but now

In 2024, the US Centers for Disease Control and Prevention published “what could well be the most important table in modern public health”, said Tom

China-rooted Corxel raises up to $287M for GLP-1 pill with global ambitions  Endpoints News

WICHITA FALLS, Texas, Jan. 22, 2026 /PRNewswire/ — CoreAge Rx, a telehealth pharmacy specializing in weight management solutions, today announced a pricing structure designed to

The US group has re-hired former CEO Joe Scalzo as sales falter and as GLP-1 trend presents opening for Atkins brand.

6 New Weight Loss Drugs That Could Dethrone Ozempic  Gizmodo What difference will a GLP-1 pill make? Wisconsin weight loss physician weighs in  wpr.org Powerful New Weight-Loss

Insilico Medicine, a U.S.-based, Hong Kong-listed AI drug discovery company, is launching a new service that will train general-purpose large language models, like OpenAI’s GPT

As millions quit GLP-1 drugs and weight rebounds faster than expected, food makers face rising pressure around nutrition, trust and mental health.

Research has found that natural compounds could affect GLP-1

Good morning, everyone, and welcome to the middle of the holiday-shortened week on this side of the pond. Congratulations on making it this far, and remember

THURSDAY, Jan. 22, 2026 — With more studies emerging, GLP-1 and dual GIP/GLP-1 medications have become well-established options for those with obesity or type 2

2026-01-22T11:00:00.000Z Save this storySave this story Save this storySave this story In the new Ryan Murphy horror thriller “The Beauty,” a virus turns its hosts

As GLP-1 use rises, research and experts warn the post-drug phase may be a critical window for weight gain, metabolic instability and unexpected pregnancies

Shanghai-based Hua Medicine wants to capture a greater share of the global diabetes market with a different approach from popular GLP-1 medicines. Many newer diabetes

Many patients may keep off lost pounds after stopping a GLP-1, US data suggests (www.reuters.com) 19:17  

Swiss healthcare group Galenica generated sales of CHF4.14 billion in the previous financial year, an increase of 5.5%. + Get the most important news from

Feeding a high-fat diet (HFD) did not alter body composition or inflammatory outcomes but resulted in impaired regulatory T cell response and compromised adaptive immunity

‘It only makes sense that the weight of passengers impacts costs,’ an equity analyst for a financial firm said

Most patients receiving a GLP-1 receptor agonist (RA) and a biologic continue co-therapy for over a year with few treatment-related adverse events. Medscape Medical News

An anonymous reader quotes a report from the New York Times: Weight-loss drugs like Ozempic have transformed millions of lives with easily administered treatments and

This systematic review evaluates preclinical and clinical evidence on glucagon-like peptide-1 receptor agonists as potential treatments for substance use disorders. Findings show consistent reductions in

Like millions of Americans, I like a good deal. With sticky inflation and rising layoffs, finding bargains has become a new American pastime, which should

New research from Cornell University has tracked how households change their spending after someone starts taking GLP-1 medications like Ozempic and Wegovy, and the numbers